STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW
Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however,...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Abednego Kristande Gwiharto [verfasserIn] Cecep Suhandi [verfasserIn] Cheryl Alodya [verfasserIn] Rano K. Sinurya [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch ; Indonesisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Keluwih - Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021, 3(2021), 1 |
|---|---|
| Übergeordnetes Werk: |
volume:3 ; year:2021 ; number:1 |
| Links: |
|---|
| DOI / URN: |
10.24123/kesdok.V3i1.4063 |
|---|
| Katalog-ID: |
DOAJ070257477 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ070257477 | ||
| 003 | DE-627 | ||
| 005 | 20230501210010.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.24123/kesdok.V3i1.4063 |2 doi | |
| 035 | |a (DE-627)DOAJ070257477 | ||
| 035 | |a (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a ind | ||
| 100 | 0 | |a Abednego Kristande Gwiharto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. | ||
| 650 | 4 | |a effectiveness | |
| 650 | 4 | |a high income councries | |
| 650 | 4 | |a influenza vaccine | |
| 650 | 4 | |a low income countries | |
| 650 | 4 | |a middle income countries | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Cecep Suhandi |e verfasserin |4 aut | |
| 700 | 0 | |a Cheryl Alodya |e verfasserin |4 aut | |
| 700 | 0 | |a Rano K. Sinurya |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Keluwih |d Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021 |g 3(2021), 1 |w (DE-627)DOAJ078626242 |x 27156419 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2021 |g number:1 |
| 856 | 4 | 0 | |u https://doi.org/10.24123/kesdok.V3i1.4063 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd |z kostenfrei |
| 856 | 4 | 0 | |u https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2715-6419 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2021 |e 1 | ||
| author_variant |
a k g akg c s cs c a ca r k s rks |
|---|---|
| matchkey_str |
article:27156419:2021----::tdeetvtsasnnlezu |
| hierarchy_sort_str |
2021 |
| publishDate |
2021 |
| allfields |
10.24123/kesdok.V3i1.4063 doi (DE-627)DOAJ070257477 (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd DE-627 ger DE-627 rakwb eng ind Abednego Kristande Gwiharto verfasserin aut STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. effectiveness high income councries influenza vaccine low income countries middle income countries Medicine R Cecep Suhandi verfasserin aut Cheryl Alodya verfasserin aut Rano K. Sinurya verfasserin aut In Keluwih Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021 3(2021), 1 (DE-627)DOAJ078626242 27156419 nnns volume:3 year:2021 number:1 https://doi.org/10.24123/kesdok.V3i1.4063 kostenfrei https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd kostenfrei https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 kostenfrei https://doaj.org/toc/2715-6419 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 3 2021 1 |
| spelling |
10.24123/kesdok.V3i1.4063 doi (DE-627)DOAJ070257477 (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd DE-627 ger DE-627 rakwb eng ind Abednego Kristande Gwiharto verfasserin aut STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. effectiveness high income councries influenza vaccine low income countries middle income countries Medicine R Cecep Suhandi verfasserin aut Cheryl Alodya verfasserin aut Rano K. Sinurya verfasserin aut In Keluwih Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021 3(2021), 1 (DE-627)DOAJ078626242 27156419 nnns volume:3 year:2021 number:1 https://doi.org/10.24123/kesdok.V3i1.4063 kostenfrei https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd kostenfrei https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 kostenfrei https://doaj.org/toc/2715-6419 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 3 2021 1 |
| allfields_unstemmed |
10.24123/kesdok.V3i1.4063 doi (DE-627)DOAJ070257477 (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd DE-627 ger DE-627 rakwb eng ind Abednego Kristande Gwiharto verfasserin aut STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. effectiveness high income councries influenza vaccine low income countries middle income countries Medicine R Cecep Suhandi verfasserin aut Cheryl Alodya verfasserin aut Rano K. Sinurya verfasserin aut In Keluwih Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021 3(2021), 1 (DE-627)DOAJ078626242 27156419 nnns volume:3 year:2021 number:1 https://doi.org/10.24123/kesdok.V3i1.4063 kostenfrei https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd kostenfrei https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 kostenfrei https://doaj.org/toc/2715-6419 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 3 2021 1 |
| allfieldsGer |
10.24123/kesdok.V3i1.4063 doi (DE-627)DOAJ070257477 (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd DE-627 ger DE-627 rakwb eng ind Abednego Kristande Gwiharto verfasserin aut STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. effectiveness high income councries influenza vaccine low income countries middle income countries Medicine R Cecep Suhandi verfasserin aut Cheryl Alodya verfasserin aut Rano K. Sinurya verfasserin aut In Keluwih Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021 3(2021), 1 (DE-627)DOAJ078626242 27156419 nnns volume:3 year:2021 number:1 https://doi.org/10.24123/kesdok.V3i1.4063 kostenfrei https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd kostenfrei https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 kostenfrei https://doaj.org/toc/2715-6419 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 3 2021 1 |
| allfieldsSound |
10.24123/kesdok.V3i1.4063 doi (DE-627)DOAJ070257477 (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd DE-627 ger DE-627 rakwb eng ind Abednego Kristande Gwiharto verfasserin aut STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. effectiveness high income councries influenza vaccine low income countries middle income countries Medicine R Cecep Suhandi verfasserin aut Cheryl Alodya verfasserin aut Rano K. Sinurya verfasserin aut In Keluwih Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021 3(2021), 1 (DE-627)DOAJ078626242 27156419 nnns volume:3 year:2021 number:1 https://doi.org/10.24123/kesdok.V3i1.4063 kostenfrei https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd kostenfrei https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 kostenfrei https://doaj.org/toc/2715-6419 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 3 2021 1 |
| language |
English Indonesian |
| source |
In Keluwih 3(2021), 1 volume:3 year:2021 number:1 |
| sourceStr |
In Keluwih 3(2021), 1 volume:3 year:2021 number:1 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
effectiveness high income councries influenza vaccine low income countries middle income countries Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Keluwih |
| authorswithroles_txt_mv |
Abednego Kristande Gwiharto @@aut@@ Cecep Suhandi @@aut@@ Cheryl Alodya @@aut@@ Rano K. Sinurya @@aut@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
DOAJ078626242 |
| id |
DOAJ070257477 |
| language_de |
englisch Sangiang |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ070257477</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230501210010.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.24123/kesdok.V3i1.4063</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ070257477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ind</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Abednego Kristande Gwiharto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">high income councries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">influenza vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">low income countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">middle income countries</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cecep Suhandi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cheryl Alodya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rano K. Sinurya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Keluwih</subfield><subfield code="d">Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021</subfield><subfield code="g">3(2021), 1</subfield><subfield code="w">(DE-627)DOAJ078626242</subfield><subfield code="x">27156419</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.24123/kesdok.V3i1.4063</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2715-6419</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield></datafield></record></collection>
|
| author |
Abednego Kristande Gwiharto |
| spellingShingle |
Abednego Kristande Gwiharto misc effectiveness misc high income councries misc influenza vaccine misc low income countries misc middle income countries misc Medicine misc R STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW |
| authorStr |
Abednego Kristande Gwiharto |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)DOAJ078626242 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
27156419 |
| topic_title |
STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW effectiveness high income councries influenza vaccine low income countries middle income countries |
| topic |
misc effectiveness misc high income councries misc influenza vaccine misc low income countries misc middle income countries misc Medicine misc R |
| topic_unstemmed |
misc effectiveness misc high income councries misc influenza vaccine misc low income countries misc middle income countries misc Medicine misc R |
| topic_browse |
misc effectiveness misc high income councries misc influenza vaccine misc low income countries misc middle income countries misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Keluwih |
| hierarchy_parent_id |
DOAJ078626242 |
| hierarchy_top_title |
Keluwih |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)DOAJ078626242 |
| title |
STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW |
| ctrlnum |
(DE-627)DOAJ070257477 (DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd |
| title_full |
STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW |
| author_sort |
Abednego Kristande Gwiharto |
| journal |
Keluwih |
| journalStr |
Keluwih |
| lang_code |
eng ind |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
txt |
| author_browse |
Abednego Kristande Gwiharto Cecep Suhandi Cheryl Alodya Rano K. Sinurya |
| container_volume |
3 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Abednego Kristande Gwiharto |
| doi_str_mv |
10.24123/kesdok.V3i1.4063 |
| author2-role |
verfasserin |
| title_sort |
studi efektivitas vaksin influenza: updated review |
| title_auth |
STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW |
| abstract |
Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. |
| abstractGer |
Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. |
| abstract_unstemmed |
Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW |
| url |
https://doi.org/10.24123/kesdok.V3i1.4063 https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063 https://doaj.org/toc/2715-6419 |
| remote_bool |
true |
| author2 |
Cecep Suhandi Cheryl Alodya Rano K. Sinurya |
| author2Str |
Cecep Suhandi Cheryl Alodya Rano K. Sinurya |
| ppnlink |
DOAJ078626242 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.24123/kesdok.V3i1.4063 |
| up_date |
2024-07-03T13:50:42.745Z |
| _version_ |
1803566074035175424 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ070257477</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230501210010.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.24123/kesdok.V3i1.4063</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ070257477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJc85aad5e4c1d4d689a7fa532403ee1dd</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ind</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Abednego Kristande Gwiharto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">STUDI EFEKTIVITAS VAKSIN INFLUENZA: UPDATED REVIEW</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Influenza is caused by a rapidly mutating viruse that consists of 2 types, namely type A with the H1N1 and H3N2 genotypes and type B. Influenza caused global mortality with 250,000-500,000 death in 2009. The effectiveness of vaccines also changes regarding the mutation of influenza viruses, however, in the development and utilization of influenza vaccines should be supported by the economic status of a country. Up to now, there are many countries that have not prioritized the utilization of influenza vaccines. The target of influenza vaccination are children and adults (< 60 years old). The purpose of this review was to determine the effectiveness of influenza vaccines from various countries and categorized based on their income. This review used Medline, Elsevier, and BMC Public Health as the database with the keywords "Effectiveness" and "Influenza vaccine". Then, the articles are selected based on inclusion and exclusion criteria. Based on the initial search there are 784 articles that match the keywords, and only 13 articles met the criteria. These articles are classified based on the center of the study in order to classify based on their national income; 5 studies in high income countries, 5 studies in upper-middle income countries, 3 studies in lower-middle income countries, and 1 study in low income countries. The results showed that the administration of influenza vaccine in high income and upper-middle income countries is quite effective for type A H1N1 genotypes, where as H3N2 is less effective. In the lower-middle income countries, the utilization of vaccines with type A H3N2 genotypes was effective, however, in the low-income countries, the effectiveness of vaccines has not been justified due to the limited study of type of influenza and the administration of influenza vaccines in those countries.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">high income councries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">influenza vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">low income countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">middle income countries</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cecep Suhandi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cheryl Alodya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rano K. Sinurya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Keluwih</subfield><subfield code="d">Direktorat Penerbitan dan Publikasi Ilmiah Universitas Surabaya, 2021</subfield><subfield code="g">3(2021), 1</subfield><subfield code="w">(DE-627)DOAJ078626242</subfield><subfield code="x">27156419</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.24123/kesdok.V3i1.4063</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/c85aad5e4c1d4d689a7fa532403ee1dd</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://journal.ubaya.ac.id/index.php/kesdok/article/view/4063</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2715-6419</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield></datafield></record></collection>
|
| score |
7.4007235 |